This lab focuses on TSPO related research and it's pathways. In a series of studies, we have shown that ligands active at the TSPO can alleviate inflammatory responses in the CNS and in the periphery. In addition, it was demonstrated that the TSPO ligands can prevent the harmful effects of cigarette smoke on lung and heart cells. These accumulated data suggest that TSPO ligands have the potential role in the treatment of inflammatory and neuro-degenerative diseases. In addition, we developed a drug delivery based on liposomes for the treatment of neuro-degenerative and brain diseases.